Clinical Trials Directory

Trials / Completed

CompletedNCT01607515

Non Invasive Measurement of Cardiac Index by Impedance Cardiography

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
89 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg in the right heart catheterization. There are different forms of PH defined in the classification of Dana Point 2008. PH is diagnosed with right heart catheterization but there are other non invasive methods which can be used for screening like echocardiography, stress echocardiography and cardio pulmonary exercise testing. For prognosis of PH patients the limitation of the pulmonary circulation is very important. Therefore the cardiac index (CI) is a good parameter for the right ventricular function. The gold standard for CI measures is the thermodilution, an invasive method performed during right heart catheterization.

Detailed description

In this study the investigators want to evaluate the impedance cardiography (ICG) as a non invasive method for CI measurement. An alternating current of max 400µA and 45 kHz is conducted through the body. The way of the smallest resistance is the blood in the aorta. The impedance changes with the pulsatile blood flow. Out of the Impedance change there can be calculated the CI.

Conditions

Interventions

TypeNameDescription
OTHERImpedance cardiographynoninvasive measure of cardiac index by impedance cardiography.

Timeline

Start date
2012-03-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2012-05-30
Last updated
2015-09-09

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01607515. Inclusion in this directory is not an endorsement.